| Yahoo! Health - My Alerts - Edit Alert |
| Monday, Feb 25, 2013 01:03 AM EST | |
| Pretty in pink Sun, 24 Feb, 2013 09:56 PM PST Sentinel photo by TIM SHUMAKER Breast cancer survivors from Mifflin and Juniata counties attend the Penn State Lady Lions Pink Zone basketball game Sunday evening at the Bryce Jordan Center in University Park. They are: from left, front, Judy Araway, Darlis Huffman, Karin Fitzgerald, Betty Bilheimer, Kathy Stimely and Sharon Copenhaver; back, Anna Beachel, Jamie Fisher, Kim McKnight, Stephanie ... Attitudes on PSA hinge on how test is described Sun, 24 Feb, 2013 09:41 PM PST Three approaches to explaining the screening resulted in varying percentages of patients who identified reduced risk of prostate cancer death as its most important aspect. Sydney scientists target cancer genes Sun, 24 Feb, 2013 09:30 PM PST ABOUT half of Australia's thousands of cancer patients could eventually benefit from a smart-drug project at a Sydney hospital. Majority of Missouri tan salons allow pre-teens Sun, 24 Feb, 2013 09:27 PM PST ( Washington University School of Medicine ) A survey of tanning salon operators in Missouri shows that 65 percent would allow children as young as 10 to 12 years old to use tanning beds. That's despite evidence that any tanning bed use increases the risk of all skin cancers, including melanoma, the deadliest form of skin cancer, later in life. Screening could avert 12,000 lung cancer deaths each year in the United States Sun, 24 Feb, 2013 09:27 PM PST ( Wiley ) Screening for lung cancer with low-dose computed tomography (LDCT) in all screening-eligible current and former smokers has the potential to avert approximately 12,000 lung cancer deaths each year in the United States. That is the conclusion of a new analysis published early online in CANCER, a peer-reviewed journal of the American Cancer Society. By providing a national estimate of ... FDA Approves Genentech's Kadcyla (Ado-Trastuzumab Emtansine), The First Antibody-Drug Conjugate For Treating HER2 ... Sun, 24 Feb, 2013 09:22 PM PST Genentech, a member of the Roche Group recently announced that the U.S. Food and Drug Administration (FDA) has approved Kadcyla(ado-trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive metastatic breast cancer (mBC) who have received prior treatment with Herceptin (trastuzumab) and a taxane chemotherapy. Sheriff's office faces suit over jailed patient's death Sun, 24 Feb, 2013 09:16 PM PST MIDDLETON -- The family of a cancer patient who died in 2010 after he was allegedly deprived of his cancer medication for a week while in custody at Middleton Jail has filed a $2 million wrongful death lawsuit against the Essex County Sheriff's Depar CT Scans for Lung Cancer May Save Lives livescience.com Sun, 24 Feb, 2013 09:13 PM PST Screening heavy smokers for lung cancer with a CT scan could potentially prevent thousands of deaths from lung cancer a year, a new study suggests. 4 Things You Might Want to Check Out This Week Sun, 24 Feb, 2013 09:12 PM PST Free educational seminars 'Estate, Financial and Gift Planning' and 'Challenges to Providing Cancer Care Today,' will be held Thursday and March 27 at 4:30 p.m. at the Regional Cancer Center, 2500 W. 12th St. Admission is free but space is limited. For more information or to register, visit www.trcc.org or call 836-2679. Health briefs Sun, 24 Feb, 2013 09:12 PM PST The American Cancer Society will hold a regional kickoff event in Erie for a nationwide cancer prevention study. | |
|

No comments:
Post a Comment